Skip to main content
Top
Published in: Digestive Diseases and Sciences 7/2019

01-07-2019 | Respiratory Microbiota | Correction

Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose

Authors: Jessica R. Allegretti, Monika Fischer, Sashidhar V. Sagi, Matthew E. Bohm, Hala M. Fadda, Sejal R. Ranmal, Shrish Budree, Abdul W. Basit, Dean L. Glettig, Eva L. de la Serna, Amanda Gentile, Ylaine Gerardin, Sonia Timberlake, Rotem Sadovsky, Mark Smith, Zain Kassam

Published in: Digestive Diseases and Sciences | Issue 7/2019

Login to get access

Excerpt

The original version of the article unfortunately contained an error in article title. The corrected title is ‘Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose’. …
Metadata
Title
Correction to: Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Low Dose
Authors
Jessica R. Allegretti
Monika Fischer
Sashidhar V. Sagi
Matthew E. Bohm
Hala M. Fadda
Sejal R. Ranmal
Shrish Budree
Abdul W. Basit
Dean L. Glettig
Eva L. de la Serna
Amanda Gentile
Ylaine Gerardin
Sonia Timberlake
Rotem Sadovsky
Mark Smith
Zain Kassam
Publication date
01-07-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 7/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05527-4

Other articles of this Issue 7/2019

Digestive Diseases and Sciences 7/2019 Go to the issue

Stanford Multidisciplinary Seminars

Open-and-Shut Case: An Uncommon Cause of GI Bleeding

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine